Akoya Biosciences enables high-parameter, deep proteomic profiling of tissues.
Initial public offering in 2021 (NASDAQ:AKYA).
Menu
Menu
Akoya Biosciences enables high-parameter, deep proteomic profiling of tissues.
Initial public offering in 2021 (NASDAQ:AKYA).
300 Montgomery Street
Suite 1130
San Francisco, CA 94104
